Emollients to Prevent Pediatric Eczema: A Randomized Clinical Trial

Area of Science:

• Dermatology
• Pediatrics
• Allergy Immunology

Background:

• Atopic dermatitis (AD) is a common childhood condition with significant global health implications.
• AD is associated with increased risk for developing food allergies and asthma.
• Limited research exists on primary AD prevention using emollients in infants without pre-selected risk factors.

Purpose of the Study:

• To investigate the efficacy of daily emollient intervention for primary prevention of AD in a general infant population.
• To determine if emollient use starting by 9 weeks of age reduces AD incidence by 24 months.

Main Methods:

• A randomized, decentralized pragmatic clinical trial involving 1247 infant-parent dyads.
• Participants were randomized to either daily full-body emollient application or a control group refraining from emollient use.
• Physician-diagnosed AD by 24 months was the primary outcome, with data collected via medical records and electronic surveys.

Main Results:

• The cumulative incidence of AD by 24 months was 36.1% in the emollient group versus 43.0% in the control group (Relative Risk [RR] = 0.84).
• A significant reduction in AD incidence was observed in the emollient group (RR = 0.75), particularly in infants not at high risk.
• A protective effect was noted in households with a dog (RR = 0.68), with no increased adverse events.

Conclusions:

• Daily emollient application initiated before 9 weeks of age effectively reduces AD incidence in a general US infant population.
• This intervention represents a practical approach to decrease the burden of AD in community pediatric care.
• Early emollient use may be a valuable strategy for primary prevention of atopic dermatitis.